The single-use bioprocessing connectors market is witnessing an unprecedented surge, revolutionizing the realm of biopharmaceutical production across the globe. This article delves into the multifaceted dynamics driving this market growth, exploring its crucial segments, regional variations, and
The discovery of a nematode, known as Panagrolaimus kolymaensis, unearthed from the depths of the Siberian permafrost has astonished scientists. This microscopic worm managed to survive in a state of cryptobiosis for an astounding 46,000 years. Over this period, it remained suspended in a
As the landscape of biopharmaceutical manufacturing undergoes significant changes, Danaher Corporation stands at a pivotal crossroads with the potential to lead through its innovative strategies and products. At the TD Cowen Health Care Conference, Danaher President and CEO Rainer Blair emphasized
Repligen, an innovative leader in bioprocess technology, has made a strategic move by acquiring essential upstream Process Analytical Technology (PAT) assets from 908 Devices for a total of $70 million. This acquisition should be viewed as more than just a simple addition of technology; it
We are joined today by Ivan Kairatov, a seasoned biopharma expert with extensive knowledge in technology, innovation, and research and development within the industry. In this interview, we will discuss the ClaraTM 6 Well Cell Culture plates introduced by Porvair Sciences, focusing on their
The possibility of creating complex three-dimensional human tissues from diverse biological materials has always been an intriguing concept within medical research. The groundbreaking innovation known as the Electrospider, developed by Bio3DPrinting, a spinoff from Italy's University of Pisa,
